Poolbeg Pharma PLC (LON:POLB – Get Free Report)’s share price was up 11.3% during mid-day trading on Tuesday . The stock traded as high as GBX 3.56 ($0.05) and last traded at GBX 3.56 ($0.05). Approximately 1,516,882 shares traded hands during trading, a decline of 37% from the average daily volume of 2,394,207 shares. The stock had previously closed at GBX 3.20 ($0.04).
Poolbeg Pharma Stock Performance
The company’s fifty day simple moving average is GBX 2.83 and its 200-day simple moving average is GBX 4.43. The company has a market capitalization of £18.14 million, a P/E ratio of 0.00 and a beta of 2.11.
Poolbeg Pharma (LON:POLB – Get Free Report) last issued its earnings results on Tuesday, May 20th. The company reported GBX (1.16) (($0.02)) earnings per share (EPS) for the quarter. On average, sell-side analysts predict that Poolbeg Pharma PLC will post -0.68 EPS for the current year.
Poolbeg Pharma Company Profile
Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs. Poolbeg comprises a strong and growing portfolio of development assets.
See Also
- Five stocks we like better than Poolbeg Pharma
- Using the MarketBeat Dividend Yield Calculator
- Ulta’s Beautiful Q1 Earnings Report Points to More Gains Ahead
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Top 3 ETFs Defense Hawks Are Buying
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Zscaler Will Hit $360 Soon: Here’s the How and Why
Receive News & Ratings for Poolbeg Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Poolbeg Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
